Market cap
$698 Mln
Revenue (TTM)
$250 Mln
P/E Ratio
141.8
P/B Ratio
3.5
Div. Yield
0.5 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -5.63 | 1.00 | 3.04 | 4.43 | 12.45 |
| EBIT | 521.59 | -27.08 | -10.33 | 25.60 | 12.11 |
| Net Profit | 168.42 | -40.32 | 874.19 | 38.19 | 5.28 |
| EPS | 165.89 | -42.44 | 710.00 | 35.60 | 2.68 |
| Book Value | -- | -- | 14.11 | -22.84 | -15.20 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -37.55 | -21.32 | 7.05 | 4.82 | 7.39 |
| Net Margin
| -- | 0.42 | 1.92 | -- | -- |
| Return on equity
| -30.59 | -18.21 | 2.56 | 3.88 | -1.29 |
| Return on Capital
| -17.26 | -10.26 | -- | 1.93 | -0.55 |
| Return on Assets
| -14.92 | -8.87 | 0.87 | 1.56 | -0.45 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.91 | 1.14 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
1.93
|
-0.55
|
-53.17
|
0.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
2.56
Lower than Peers by 2.39
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
2.56
|
3.88
|
-1.29
|
-94.36
|
0.24
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
0.87
Lower than Peers by 1.59
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
0.87
|
1.56
|
-0.45
|
-45.87
|
0.14
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
7.05
Lower than Peers by 1.42
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
7.05
|
4.82
|
7.39
|
-124.87
|
2.00
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
1.92
Lower than Peers by 2.75
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
1.92
|
2.69
|
-0.82
|
-117.60
|
0.42
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
3.04
Lower than Peers by 5.44
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
3.04
|
0.03
|
0.11
|
-0.01
|
0.19
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-10.33
Lower than Peers by 20.98
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
-10.33
|
-32.58
|
106.60
|
-6,261.86
|
-41.27
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
874.19
Higher than Peers by 860.64
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
874.19
|
440.02
|
99.22
|
-27,438.28
|
-50.29
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
710.00
Higher than Peers by 689.49
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
710.00
|
4.33
|
0.99
|
-273.72
|
-0.51
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
5.55
Lower than Peers by 1.46
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
5.55
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
0.91
|
1.14
|
1.59
|
0.47
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
0.04
|
0.05
|
0.65
|
0.02
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.07
Lower than Peers by 0.75
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
2.07
|
1.72
|
0.63
|
2.47
|
2.74
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
1.52
Lower than Peers by 0.52
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
1.52
|
1.29
|
0.47
|
1.73
|
1.94
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
1.86
Lower than Peers by 3.10
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
1.86
|
1.12
|
1.50
|
-47.38
|
0.92
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
13.78
Lower than Peers by 2.68
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
13.78
|
17.70
|
17.42
|
18.07
|
19.42
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.45
Lower than Peers by 0.05
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
0.45
|
0.58
|
0.55
|
0.39
|
0.32
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
63.09
|
61.40
|
68.94
|
69.83
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
103.99
|
117.63
|
148.23
|
126.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
21.46
|
23.89
|
26.81
|
30.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
--
|
145.63
|
155.15
|
190.36
|
166.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
141.77
Higher than Peers by 97.32
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
141.77
|
73.03
|
-326.35
|
-2.33
|
1,010.99
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
3.54
Lower than Peers by 0.29
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
3.54
|
2.63
|
4.03
|
4.07
|
2.39
|
|
Peer Median
|
3.84
|
--
|
--
|
--
|
--
|
Dividend Yield
0.54
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
0.54
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
18.14
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
18.14
|
17.91
|
18.85
|
-3.33
|
29.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
698
Higher than Peers by 156
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Mesa Laboratories (MLAB)
|
698
|
--
|
--
|
--
|
--
|
|
Peer Median
|
542
|
--
|
--
|
--
|
--
|